0

A 887826

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1266212810
CAS1266212-81-0
MDL NumberMFCD20926345
Molecular Weight480.99
InChI KeyJPJGFWKHSMUKFO-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥5 mg/mL
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

A Cellular Model of Brugada Syndrome With SCN10A Variants Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Ibrahim El-Battrawy, Sebastian Albers, Lukas Cyganek, Zhihan Zhao, Huan Lan, Xin Li, Qiang Xu, Mandy Kleinsorge, Mengying Huang, Zhenxing Liao, Rujia Zhong, Boris Rudic, Jonas Müller, Hendrik Dinkel, Siegfried Lang, etc.

Europace. 2019 Sep 1;21(9):1410-1421.

PMID: 31106349

1

A-887826 Is a Structurally Novel, Potent and Voltage-Dependent Na(v)1.8 Sodium Channel Blocker That Attenuates Neuropathic Tactile Allodynia in Rats

Xu-Feng Zhang, Char-Chang Shieh, Mark L Chapman, Mark A Matulenko, Ahmed H Hakeem, Robert N Atkinson, Michael E Kort, Brian E Marron, Shailen Joshi, Prisca Honore, Connie R Faltynek, Douglas S Krafte, Michael F Jarvis

Neuropharmacology. 2010 Sep;59(3):201-7.

PMID: 20566409

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode